Global COPD Drugs Market Research Report 2012-2024
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 Bronchodilators
- 1.2.1.2 PDE-4 Inhibitors
- 1.2.1.3 Steroids
- 1.2.1.4 Combination Therapies
- 1.2.1.5 Others
- 1.2.2 by Application
- 1.2.2.1 Hospitals
- 1.2.2.2 Clinics
- 1.2.2.3 Others
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 Bronchodilators Market, 2013-2018
- 4.1.2 PDE-4 Inhibitors Market, 2013-2018
- 4.1.3 Steroids Market, 2013-2018
- 4.1.4 Combination Therapies Market, 2013-2018
- 4.1.5 Others Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 Bronchodilators Market Forecast, 2019-2024
- 4.2.2 PDE-4 Inhibitors Market Forecast, 2019-2024
- 4.2.3 Steroids Market Forecast, 2019-2024
- 4.2.4 Combination Therapies Market Forecast, 2019-2024
- 4.2.5 Others Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 Hospitals Market, 2013-2018
- 5.1.2 Clinics Market, 2013-2018
- 5.1.3 Others Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 Hospitals Market Forecast, 2019-2024
- 5.2.2 Clinics Market Forecast, 2019-2024
- 5.2.3 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Global Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 Pfizer
- 8.2 Novartis
- 8.3 GlaxoSmithKline
- 8.4 Merck
- 8.5 Abbott Laboratories
- 8.6 Boehringer Ingelheim
- 8.7 AstraZeneca
- 8.8 Roche Holding AG
- 8.9 Teva Pharmaceutical Industries
- 8.10 Vectura Group
- 8.11 Mylan NV
9 Conclusion
Summary
The global COPD Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Pfizer
Novartis
GlaxoSmithKline
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Mylan NV
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospitals
Clinics
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa